Invidia Capital Management Appoints Matt Bennett as Partner

Invidia资本管理公司任命马特·贝内特为合伙人

Veteran healthcare investor and operator brings three decades of experience to Invidia's growing platform.

资深医疗保健投资者和运营商为Invidia不断发展的平台带来了三十年的经验。

NEW YORK, August 25, 2025-- Invidia Capital Management, a healthcare-focused middle-market investment firm, announced today the appointment of Matt Bennett as a Partner. With more than 30 years of experience, Matt is expected to bolster Invidia's mission to invest in and scale innovative healthcare businesses across North America..

纽约，2025年8月25日——专注于医疗保健领域的中型市场投资公司Invidia Capital Management今日宣布任命马特·贝内特为合伙人。马特拥有30多年的丰富经验，预计将加强Invidia在北美投资并扩展创新医疗保健业务的使命。

Prior to joining Invidia, Matt Bennett was a Managing Director and Operating Partner at New Mountain Capital, beginning in 2016, where he focused on growth transactions across a range of industries.

在加入Invidia之前，马特·贝内特自2016年起担任New Mountain Capital的董事总经理和运营合伙人，专注于跨多个行业的增长型交易。

Prior to being at New Mountain headquarters, Matt served as an executive leader of two New Mountain companies, CIOX Health (now Datavant) and Ikaria. He was CEO of CIOX from 2015-2016. Prior to CIOX, Matt held multiple executive roles at Ikaria (2007-2015) and served as Executive Vice President, Global Medical Operations and Chief Financial Officer, in addition to other roles..

在加入纽曼总部之前，马特曾担任纽曼两家公司的高管，分别是CIOX Health（现为Datavant）和Ikaria。他在2015年至2016年期间担任CIOX的首席执行官。在CIOX之前，马特在Ikaria（2007-2015）担任过多个高管职位，包括执行副总裁、全球医疗运营和首席财务官等职务。

Before joining Ikaria, he was Executive Vice President, Chief Administrative Officer and Chief Business Officer at VIASYS Healthcare, Inc. (NYSE: VAS), a publicly traded medtech firm with operations in respiratory care, neurology, orthopedics and surgical products.

在加入Ikaria之前，他曾担任VIASYS Healthcare, Inc.（纽约证券交易所代码：VAS）的执行副总裁、首席行政官和首席商务官，这是一家公开上市的医疗技术公司，业务涵盖呼吸护理、神经科、骨科和外科产品。

'Joining Invidia is an exciting next chapter for me,' said Mr. Bennett. 'Jo has built a firm grounded in conviction and collaboration, with a disciplined and differentiated approach to healthcare investing. I'm eager to contribute to the platform's continued success and help shape the future of healthcare through meaningful partnerships and growth transactions that improve the quality of healthcare.'.

“加入Invidia对我来说是一个令人兴奋的新篇章，”贝内特先生说。“Jo建立了一家基于信念和协作的公司，在医疗投资领域有着严谨且差异化的方法。我渴望为这一平台的持续成功做出贡献，并通过有意义的合作和促进医疗质量提升的成长型交易，帮助塑造医疗保健的未来。”

'I've long admired Matt's ability to bridge operational excellence with deep investment insights,' said Jo Natauri, Founder and Managing Partner of Invidia Capital Management. 'With over 30 years of experience as an operator in healthcare, Matt brings a unique perspective that we believe will be invaluable as we assess value creation opportunities across our portfolio.

“我长期以来一直钦佩马特将运营卓越与深刻投资洞察相结合的能力，”Invidia Capital Management创始人兼管理合伙人乔·纳塔乌里表示。“马特在医疗保健领域拥有超过30年的运营经验，带来了独特的视角，我们相信这将在评估我们投资组合中的价值创造机会时发挥不可估量的作用。”

We're thrilled to welcome him to the team.'.

我们非常高兴他加入团队。

ABOUT INVIDIA CAPITAL MANAGEMENT

关于英维迪亚资本管理

Invidia Capital Management is a healthcare-oriented private equity firm based in New York and focused on middle market investments in North America. It was founded in 2024 by Jo Natauri, the former Global Head of Private Healthcare Investing at Goldman Sachs.

Invidia Capital Management是一家总部位于纽约、专注于北美中型市场投资的医疗保健类私募股权公司。该公司由前高盛全球私人医疗投资主管Jo Natauri于2024年创立。